Taiwan FDA registration cfe36f237a85ffbfca23f351241aac49

Huayu-Tumor marker DR-70 enzyme immunoassay diagnostic reagent

TW: 華宇-腫瘤標記DR-70酵素免疫分析診斷試劑
Taiwan flagTaiwan·Risk Class 2·AMDL DIAGNOSTIC INC.·Registered Dec 01, 2006 – Dec 01, 2016Cancelled
Registration details
Analysis ID
cfe36f237a85ffbfca23f351241aac49
Customs Code
DHA00601781800
Company information
Manufacturer Country
United States
Authorized Representative
UNI PHARMA CO., LTD.
Product details
Intended Use
The amount of DR-70 in human serum is measured.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.6010 腫瘤相關抗原免疫試驗系統
Import Information
import
Dates and status
Registration Date
Dec 01, 2006
Expiry Date
Dec 01, 2016
Cancellation Date
Apr 25, 2018
Cancellation information
Status
Logged out
Reason
自行鍵入
Companies making similar products

Top companies providing products similar to "Huayu-Tumor marker DR-70 enzyme immunoassay diagnostic reagent"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Huayu-Tumor marker DR-70 enzyme immunoassay diagnostic reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cfe36f237a85ffbfca23f351241aac49 and manufactured by AMDL DIAGNOSTIC INC.. The authorized representative in Taiwan is UNI PHARMA CO., LTD..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Shiji Biomedical Co., Ltd. Taipei Plant, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations